{"id":4452,"date":"2023-04-25T10:24:08","date_gmt":"2023-04-25T10:24:08","guid":{"rendered":"https:\/\/integratedcarejournal.com\/?p=4452"},"modified":"2023-05-10T16:04:22","modified_gmt":"2023-05-10T16:04:22","slug":"iqvia-optimising-respiratory-pathways-nhs","status":"publish","type":"post","link":"https:\/\/integratedcarejournal.com\/iqvia-optimising-respiratory-pathways-nhs\/","title":{"rendered":"How IQVIA is optimising respiratory pathways to enable long-term NHS recovery"},"content":{"rendered":"
The NHS has been significantly impacted during the pandemic and must prioritise workforce investment, COVID-19 recovery and a reduction in the backlog of care. To support patients, key objectives have been outlined in the NHS Long Term Plan<\/a> and the NHS Operational Planning and Contracting Guidance<\/a>. These objectives support the integrated care systems (ICSs) priorities to:<\/p>\n IQVIA, a human data science company, has been working with ICSs to achieve these priorities as well as the overarching aims of the NHS. Through its Interface pharmacist team, a team of clinical pharmacists and nurses who support primary care and community health services, IQVIA can support with patient identification and treatment actions, therapy reviews, patient and clinical education and flexible capacity support.<\/p>\n IQVIA were commissioned by LLR to deliver a Respiratory Optimisation Programme over a seven-week period. This clinical support was intended to ease some of the pressure caused by the backlog of care and allow vulnerable patients to receive timely support due by providing additional clinical capacity. Over the course of the programme, IQVIA were able to:<\/p>\n IQVIA\u2019s Interface pharmacists delivered 3,000 COPD clinic appointments across the LLR ICS, working with 71 practices \u2013 with 54 per cent of the pharmacy practices in the LLR ICS. Across these practices, 11,348 patients had a diagnosis of COPD recorded. 8,692 of these (77 per cent of the total) were identified as potential beneficiaries of treatment optimisation, and 7,420 of these patients (85 per cent) were invited to a COPD clinic.<\/p>\n Of those patients seen in clinic,<\/p>\n Due to the pandemic and subsequent backlog in care, many of these patients had no recorded care process in the last 12 months. After the pharmacist clinics there were significant increases to these key markers, including:<\/p>\n The seven-week support programme provided LLR with the additional clinical resource needed to assess and proactively manage patients with COPD. The increased capacity benefited the health and well-being of patients whilst the multi-disciplinary team were engaged with the review to provide ongoing, continued care.<\/p>\n About IQVIA<\/strong><\/p>\n IQVIA utilises extensive data and analytics capabilities to inform clinical decision-making.\u00a0 To support and drive key advancements towards improving patient outcomes, IQVIA is at the forefront of unlocking the potential of NHS health data to realise future health improvements for the UK and deliver transformative benefits for the patients of today and tomorrow. IQVIA believes that the value of NHS health data is not in the data per se, but in the clinical decision-making it can inform. As a trusted partner to health systems and providers, we use our extensive data and analytics capabilities to transform health outcomes and deliver pioneering biomedical research within the 95 per cent of NHS Trusts who use one or more of our services.<\/p>\n","protected":false},"excerpt":{"rendered":" As the NHS continues its recovery from Covid-19, IQVIA has been working with integrated care systems, with its analytics capabilities helping them to deliver on regional and national priorities. <\/p>\n","protected":false},"author":35,"featured_media":4453,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[58,25],"tags":[],"class_list":["post-4452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-iqvia","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/posts\/4452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/comments?post=4452"}],"version-history":[{"count":2,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/posts\/4452\/revisions"}],"predecessor-version":[{"id":4455,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/posts\/4452\/revisions\/4455"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/media\/4453"}],"wp:attachment":[{"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/media?parent=4452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/categories?post=4452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/integratedcarejournal.com\/wp-json\/wp\/v2\/tags?post=4452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\nCase study: Leicester, Leicestershire & Rutland (LLR) ICS<\/h3>\n
\n
\n
\n
\n